SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab.
Marques-Piubelli ML, Parra ER, Feng L, Soto LS, Gallardo M, Gouni S, Samaniego F, Noorani M, Hagemeister FB, Westin JR, Lee HJ, Rodriguez MA, Neelapu SS, Gunther JR, Fowler NH, Flowers CR, Wistuba II, Nastoupil LJ, Vega F, Strati P.
Marques-Piubelli ML, et al. Among authors: rodriguez ma.
Blood Adv. 2022 Jun 14;6(11):3286-3293. doi: 10.1182/bloodadvances.2022007104.
Blood Adv. 2022.
PMID: 35359004
Free PMC article.